What is Biomagnetics Diagnostics Corp. (BMGP)?

Biomagnetics Diagnostics Corp. (BMGP) is a stock in the Healthcare sector, Medical - Specialties industry. View full analysis on Stocks360.

What is the current price of BMGP?

The current price of BMGP is $0.00. Prices are updated in real time on Stocks360.

What is BMGP's price-to-earnings (PE) ratio?

BMGP's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is BMGP's market capitalization?

BMGP's market capitalization is $1,265.00, placing it in the small-cap tier.

Biomagnetics Diagnostics Corp. (BMGP)

Stock analysis · OTC · Healthcare · Medical - Specialties

$0.00

Market Cap

$1.26K

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

3.73

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

11.00K

Biomagnetics Diagnostics Corp. (BMGP) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $1.26K. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 7 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $0.00 2026-10-27 · $0.00 (+0.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Biomagnetics Diagnostics Corp.

Biomagnetics Diagnostics Corp. operates as a pioneering company at the forefront of advanced medical device development and biotechnology. The firm's diagnostic technologies prioritize the direct, real-time detection of viruses, toxins, or the disease itself. This approach differs significantly from traditional methods that rely on identifying antibodies, which are part of the body's immune response and can take several weeks to many months to manifest. The company's product portfolio features the High Throughput Screening - Magnetic Testing Platform (HTS-MTP) and the Integrity Optical Biosensor (IOBS). The HTS-MTP system is designed to provide comprehensive analysis from a single test, offering both qualitative identification of chemical elements within a substance and precise quantitative measurements of specific components. Furthermore, its optical biosensor operates on the principle of protein-receptor binding. It utilizes planar optical waveguides to bring together two or more optically tagged receptors, thereby inducing changes in fluorescence that are almost instantly recognized by tiny, integrated detectors.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	0.00×
P/B	0.00×
P/FCF (TTM)	-0.01×
EV / EBITDA	-1.21×
EV / Sales	0.00×
Earnings Yield	-35825.84%
Free Cash Flow Yield	-15534.39%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$276.95K
Net Income (TTM)	-$453.20K
Free Cash Flow (TTM)	-$62.80K
Net Debt	$275.68K
Working Capital	-$309.04K
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	-49.66%
Return on Invested Capital	-30.40%